January 18, 2025
January 1, 2025
December 30, 2024
December 29, 2024
NineSigma’s client is a leading global pharmaceutical company at the forefront of state-of-the-art biopharmaceutical research and innovation. As part of their innovation pursuits, they are launching a novel new treatment for Psoriasis, a chronic autoimmune disease that impacts over 125 million individuals globally. Psoriasis is characterized by red, scaly patches of […]
December 29, 2024
December 28, 2024
December 27, 2024
December 20, 2024
December 13, 2024
December 5, 2024
November 30, 2024
November 23, 2024
November 19, 2024
As we get older, it's normal for our thinking and memory skills to change, and there is a common misconception that a decline in mental faculties is somehow an acceptable facet of the aging process. While some decline is expected, how much is normal? Understanding what's considered a typical part […]
November 12, 2024
November 10, 2024
November 4, 2024
November 4, 2024
October 27, 2024
October 22, 2024
Stem cells are gaining ground as reparation for different diseases, immune disorders, and injuries, including multiple sclerosis (MS). Despite this, this therapy’s cost may differ greatly depending on where stem cells are transplanted. Popular MS drugs can cost upwards of $3,000 per month, according to Fox News. Clinics like Swiss […]
October 15, 2024
Many patients wish to benefit from regenerative medicine but are unsure if it's worth pursuing, as they don't know how well cell therapy works. It's certainly effective for many diseases. For some conditions, cell therapy is presumed effective and is still undergoing clinical research. Affordable stem cell therapy options are […]
October 15, 2024
October 7, 2024
American scientists Victor Ambros and Gary Ruvkun have been awarded the 2024 Nobel Prize in Medicine for their discovery of microRNA (miRNA) and its vital role in cell specialization and development in multicellular organisms. Speaking to the global media about the accolade, Ruvkun referred to the Nobel recognition as akin […]
October 5, 2024
October 4, 2024
October 1, 2024
September 30, 2024
September 27, 2024
September 22, 2024
September 21, 2024
September 19, 2024
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310
Next page